People · Operator
Named in public records as an officer, director or promoter · active 2023–2025 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ClearNote Health, Inc. | — | Biotechnology | Series C | $91.1M | $137.6M | 2025 |
| LTS1, Inc. | — | Other | Series A | $10.0M | $14.2M | 2023 |
David Mullarkey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Mullarkey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Snider | 1 | 7 |
| Christopher McGuinness | 1 | 3 |
| Paul McEwan | 1 | 3 |
| Samuel Levy | 1 | 2 |
| Stephen Quake | 1 | 2 |
| Tina Mattias Nova | 1 | 1 |
| Johan Mattias Westman | 1 | 1 |
| Samuel Mattias Levy | 1 | 1 |
| Christopher Boggess | 1 | 1 |
| Johan Mattias Westerman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.